Balyasny Asset Management LLC Thermo Fisher Scientific Inc. Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

A detailed history of Balyasny Asset Management LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 2,100 shares of TMO stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,100

Previous 2,100 -0.0%

Holding current value

$1.26 Million

Previous $1.16 Million 11.8%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$531.86 - $624.21 $55.2 Million - $64.8 Million	-103,807 Reduced 79.99%	25,963 $16.1 Million
Q2 2024 Aug 14, 2024	BUY	$541.52 - $599.02 $51.7 Million - $57.2 Million	95,433 Added 277.93%	129,770 $71.8 Million
Q1 2024 May 13, 2024	SELL	$528.82 - $599.43 $116 Million - $131 Million	-218,646 Reduced 86.43%	34,337 $20 Million
Q4 2023 Feb 14, 2024	BUY	$431.41 - $532.94 $49.4 Million - $61 Million	114,434 Added 82.59%	252,983 $134 Million
Q3 2023 Nov 14, 2023	BUY	$498.29 - $574.41 $66.6 Million - $76.8 Million	133,721 Added 2769.7%	138,549 $70.1 Million
Q2 2023 Aug 14, 2023	SELL	$508.46 - $591.13 $406,259 - $472,312	-799 Reduced 14.2%	4,828 $2.52 Million
Q1 2023 May 15, 2023	SELL	$535.0 - $604.82 $19.5 Million - $22 Million	-36,367 Reduced 86.6%	5,627 $3.24 Million
Q4 2022 Feb 14, 2023	BUY	$484.71 - $571.37 $16.2 Million - $19.1 Million	33,399 Added 388.59%	41,994 $23.1 Million
Q3 2022 Nov 14, 2022	SELL	$507.19 - $604.49 $47 Million - $56 Million	-92,584 Reduced 91.51%	8,595 $4.36 Million
Q2 2022 Aug 15, 2022	SELL	$500.9 - $612.21 $11.1 Million - $13.5 Million	-22,118 Reduced 17.94%	101,179 $55 Million
Q4 2021 Feb 14, 2022	BUY	$569.0 - $667.24 $7.31 Million - $8.58 Million	12,855 Added 11.64%	123,297 $82.3 Million
Q3 2021 Nov 15, 2021	SELL	$509.53 - $609.78 $21 Million - $25.2 Million	-41,284 Reduced 27.21%	110,442 $63.1 Million
Q2 2021 Aug 16, 2021	BUY	$441.0 - $508.24 $48.7 Million - $56.1 Million	110,449 Added 267.58%	151,726 $76.5 Million
Q1 2021 May 17, 2021	SELL	$439.85 - $518.83 $18.7 Million - $22 Million	-42,455 Reduced 50.7%	41,277 $18.8 Million
Q2 2020 Aug 14, 2020	BUY	$275.2 - $362.34 $23 Million - $30.3 Million	83,732 New	83,732 $30.3 Million
Q3 2019 Nov 14, 2019	SELL	$268.46 - $305.43 $5.07 Million - $5.77 Million	-18,877 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$257.51 - $295.55 $2.48 Million - $2.85 Million	9,639 Added 104.34%	18,877 $5.54 Million
Q1 2019 May 15, 2019	SELL	$212.17 - $273.72 $49,223 - $63,503	-232 Reduced 2.45%	9,238 $2.53 Million
Q4 2018 Feb 14, 2019	BUY	$208.47 - $251.98 $943,326 - $1.14 Million	4,525 Added 91.51%	9,470 $2.12 Million
Q3 2018 Nov 14, 2018	SELL	$205.57 - $244.32 $2.7 Million - $3.21 Million	-13,126 Reduced 72.64%	4,945 $1.21 Million
Q2 2018 Aug 14, 2018	SELL	$203.14 - $219.53 $12.3 Million - $13.3 Million	-60,370 Reduced 76.96%	18,071 $3.74 Million
Q1 2018 May 15, 2018	BUY	$192.98 - $224.11 $14.9 Million - $17.3 Million	77,241 Added 6436.75%	78,441 $16.2 Million
Q4 2017 Feb 14, 2018	SELL	$182.03 - $200.37 $30.6 Million - $33.7 Million	-168,114 Reduced 99.29%	1,200 $228,000
Q3 2017 Nov 14, 2017	BUY	$171.74 - $194.04 $29.1 Million - $32.9 Million	169,314	169,314 $32 Million

Others Institutions Holding TMO

# of Institutions

2,812

Shares Held

332M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $234B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Thermo Fisher Scientific Inc. Transaction History